Cargando…
Multiple Sclerosis: Pathogenesis and Treatment
Multiple sclerosis (MS) is a chronic inflammatory autoimmune demyelinating disease of the central nervous system. It affects approximately 400,000 people in the United States and onset is usually during young adulthood. There are four clinical forms of MS, of which relapsing remitting type is the mo...
Autores principales: | Loma, Ingrid, Heyman, Rock |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151595/ https://www.ncbi.nlm.nih.gov/pubmed/22379455 http://dx.doi.org/10.2174/157015911796557911 |
Ejemplares similares
-
Adding to the Burden: Gastrointestinal Symptoms and Syndromes in Multiple Sclerosis
por: Levinthal, David J., et al.
Publicado: (2013) -
The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis
por: Duarte-Silva, Eduardo, et al.
Publicado: (2022) -
Viruses and the pathogenesis of multiple sclerosis
por: Whitaker, John N., et al.
Publicado: (1984) -
Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and Treatment
por: Duarte-Silva, Eduardo, et al.
Publicado: (2022) -
Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
por: Liu, Rongzeng, et al.
Publicado: (2022)